 
Click Title for complete article or
click Summary for overview of each
article.
Dems'
health care plan stumbles but keeps
moving
From
Associated Press - Jun
19, 2009
WASHINGTON_Democrats got a sobering
glimpse of what it would look like if their
ambitious health care overhaul ran into a wall _
and they quickly pulled back to regroup and get
moving again. Trying to regain the initiative,
House Democrats on Friday unveiled draft
legislation they said would cover virtually all of
the nation's nearly 50 million uninsured as
President Barack Obama has
promised.
[ Summary
]
| FDA: New Treatments and
Technology |
| Click Title for complete article or
click Summary for overview of each
article.
Homeopathic
Pharmacists' Association Highlights the
Extraordinary Safety Record of Homeopathic
Medicines
From PR Newswire US -
Jun 19,
2009
The American
Association of Homeopathic Pharmacists
acknowledges the U.S. Food and Drug
Administration's action to protect the public by
sending a Warning Letter to Matrixx Innovations,
Inc., in connection with that company's sale of
Zicam intranasal zinc medications.
[ Summary
]
Fresenius
Medical Care receives FDA approval to manufacture
saline in Mexico for US dialysis
market
From
EquityBites - Jun 19,
2009
Fresenius
Medical Care North America, which supplies
products and services for dialysis patients,
announced on Thursday that its manufacturing
facility in Guadalajara, Mexico, has received US
regulatory approval to manufacture and distribute
saline solution in the US for use in dialysis
treatments.
[ Summary
]
FDA
Grants The Medicines Company Pediatric Exclusivity
for Angiomax
From PharmaLive News Archive -
Jun 18,
2009
PARSIPPANY,
NJ, Jun 19, 2009 (MARKETWIRE via COMTEX) -- The
Medicines Company announced today that the U.S.
Food and Drug Administration has granted pediatric
exclusivity for Angiomax (bivalirudin), based on
studies submitted in response to a Written Request
by the FDA to investigate the use of Angiomax in
pediatric patients aged birth to 16-years
old.
[ Summary
]
Click Title for complete article or
click Summary for overview of each
article.
State
offering free Tamiflu to some uninsured:
Prevention ? The move is aimed at preventing the
spread of H1N1 flu. [The Salt Lake
Tribune]
From Salt Lake Tribune (UT) -
Jun 19,
2009
Jun. 19--Free
Tamiflu will soon be available to some uninsured
Utahns, in an effort to stop the spread of H1N1
swine flu.
[ Summary
]
State,
Poloncarz fault Erie County on pursuing fraud in
Medicaid [The Buffalo News,
N.Y.]
From
Buffalo News (NY) - Jun
18, 2009
Jun.
18--When Erie County got the go-ahead last year to
audit Medicaid providers for fraud and abuse, the
state suggested the county start with 10 local
pharmacies. A year later, state officials still
are waiting for the county to act. "They're in a
state of dormancy," said Katherine Napoli, program
director of the state's four-year-old Medicaid
demonstration project.
[ Summary
]
| Genetics & Genomics
Research |
| Click Title for complete article or
click Summary for overview of each
article.
Avir
Green Hills: Excellent Preclinical Data on Novel
Type of Intranasal H5N1 Influenza Vaccine ?
Technology Also Suitable for Vaccination against
Swine Flu
From PharmaLive News Archive -
Jun 18,
2009
VIENNA--(BUSINESS WIRE)--Jun 19,
2009 - Studies performed in three animal models
confirmed the safety and intensive immunogenicity
of a new type of intranasal H5N1 influenza
vaccine, according to the latest preclinical study
data announced today by the Vienna based firm,
Avir Green Hills Biotechnology. The study data was
just published in PloS One, the Public Library of
Science.
[ Summary
]
Human
Genome Sciences Announces Completion of Enrollment
in Phase 2b Monthly-Dosing Trial of
Albuferon(R)
From PR Newswire US -
Jun 19,
2009
- Trial
conducted by Novartis evaluating safety and
efficacy of Albuferon administered every four
weeks in combination with ribavirin in patients
with genotypes 2 and 3 hepatitis C - Human Genome
Sciences, Inc. today announced that Novartis has
completed enrollment and initial dosing in a Phase
2b clinical trial to evaluate the safety and
efficacy of Albuferon administered monthly in
combinatio...
[ Summary
]
Seattle
Genetics Initiates Phase II Trial of SGN-35 for
Anaplastic Large Cell Lymphoma
From PharmaLive News Archive -
Jun 17,
2009
BOTHELL,
Wash.--(BUSINESS WIRE)--Jun 18, 2009 - Seattle
Genetics, Inc. (NASDAQ:SGEN), today announced that
it has initiated a phase II clinical trial of
SGN-35 for patients with relapsed or refractory
systemic anaplastic large cell lymphoma (ALCL).
SGN-35 is an antibody-drug conjugate (ADC) that
utilizes Seattle Genetics' proprietary technology
to empower antibodies by linking them to potent
cell-killing drugs.
[ Summary
]
Click Title for complete article or
click Summary for overview of each
article.
Helix
BioPharma to Present L-DOS47 Analytical Method
Development Findings at 2009 AAPS National
Biotechnology Conference
From Canada Newswire -
Jun 19,
2009
Helix
BioPharma Corp. today announced that Dr. Heman
Chao, chief scientific officer at Helix BioPharma
Corp., will be presenting a scientific poster
describing L-DOS47 analytical method development
findings at the 2009 American Association of
Pharmaceutical Scientists National Biotechnology
Conference, which runs from June 21st to 24th at
the Washington State Convention and Trade Center
in Seat...
[ Summary
]
US
gives nod to Cougar Biotech buyout by Johnson
& Johnson
From M2 Europharma -
Jun 18,
2009
18 June 2009 -
US healthcare products maker Johnson & Johnson
said today that the Federal Trade Commission has
cleared its acquisition of local bio-drug maker
Cougar Biotechnology. Johnson & Johnson agreed
to acquire Cougar last month offering to pay
USD893.7m, or USD43 per share.
[ Summary
]
Bioheart
to Introduce Improved Heart Failure Monitoring
Systems at Heart Failure Nurses Annual
Meeting
From
PR Newswire US - Jun
18, 2009
Bioheart,
Inc., a company committed to delivering
intelligent devices and biologics that help
monitor, diagnose and treat heart failure and
cardiovascular diseases announced today that the
company will be introducing its heart failure
monitoring systems at the American Association of
Heart Failure Nurses 5th Annual
Meeting.
[ Summary
]
Click Title for complete article or
click Summary for overview of each
article.
Elder
signs deal with US co for human trials of
anti-cancer drug [The Economic Times,
India]
From
Economic Times (India) - Jun 19, 2009
Jun. 19--NEW DELHI -- Elder
Pharmaceuticals has signed an agreement with
US-based MD Anderson Cancer Center to conduct
human experiments for its newly-discovered
anti-cancer drug. "The deal is unique, as the
ownership rights of the drug will lie with MD
Anderson and the manufacturing rights will be with
Elder.
[ Summary
]
Children's
National Medical Center Dedicates New Blood Donor
Center
From
PR Web - Jun 19,
2009
Children's
National Medical Center dedicated a new Edward J.
Miller, Sr., Blood Donor Center, which provides an
invaluable service to many patients who need blood
products. Children's National Medical Center
dedicated a new Edward J. Miller, Sr., Blood Donor
Center, which provides an invaluable service to
many patients who need blood
products.
[ Summary
]
Lytix
Biopharma and KAEL-GemVax Announce Joint Clinical
Trial to Combine LTX-315 and GV1001 Cancer
Immunotherapy
From PharmaLive News Archive -
Jun 18,
2009
TROMS0, Norway
and SEOUL, Korea, June 19, 2009 /PRNewswire/ --
The Norwegian biopharmaceutical company Lytix
Biopharma and Korean company KAEL-GemVax today
announced the signing of a collaborative agreement
to test lead compounds LTX-315 and GV1001 as a
combination therapy for the treatment of
cancer.
[ Summary
]
US
Court authorises generic version of
Sanofi-Aventis' Eloxatin
From M2 Europharma -
Jun 19,
2009
19 June 2009 -
The US Court has ruled that local pharmaceutical
company Hospira can market its own generic version
of the anti-cancer drug Eloxatin of French
Sanofi-Aventis. The French company had accused
Hospira of patent infringement as regards the
medicament. Following the ruling, Sanofi-Aventis
said it intended to appeal against the
decision.
[ Summary
]
Cephalon
Provides Clinical Update on Lestaurtinib in
Relapsed Acute Myelogenous
Leukemia
From PR Newswire US -
Jun 19,
2009
Cephalon, Inc.
today announced results from a pivotal clinical
trial of lestaurtinib in patients with relapsed
acute myelogenous leukemia expressing FLT3
activating mutations.
[ Summary
]
Human
Genome Sciences Announces Completion of Enrollment
in Phase 2b Monthly-Dosing Trial of
Albuferon(R)
From PR Newswire US -
Jun 19,
2009
- Trial
conducted by Novartis evaluating safety and
efficacy of Albuferon administered every four
weeks in combination with ribavirin in patients
with genotypes 2 and 3 hepatitis C - Human Genome
Sciences, Inc. today announced that Novartis has
completed enrollment and initial dosing in a Phase
2b clinical trial to evaluate the safety and
efficacy of Albuferon administered monthly in
combinatio...
[ Summary
]
Multiple
Myeloma Research Consortium Activates Clinical
Trials 30-40 Percent Faster Than Industry
Standard
From PharmaLive News Archive -
Jun 17,
2009
NORWALK,
Conn.--(BUSINESS WIRE)--Jun 18, 2009 - The
Multiple Myeloma Research Consortium, an
innovative research model comprised of a network
of 15 academic Member Institutions across North
America and leadership in Norwalk, Connecticut,
today announced preliminary data from an analysis
showing that clinical trials opened through its
clinical trials network were activated 30 to 40
percent faster than comparable clinical trials in
oncology.
[ Summary
]
Med
Discovery in-licenses new chemotherapy enhancer
technology - Press release
From PharmaLive News Archive -
Jun 17,
2009
Geneva,
Switzerland - 17 June, 2009 - Med Discovery, an
oncology company specialized in protein-based
therapeutics, is pleased to announce that it has
signed an in-licensing deal for a technology based
on RasGAP-derived peptides that enhance the effect
of genotoxins for cancer therapy.
[ Summary
]
ImmunoCellular
Therapeutics files US patent application for
cancer stem cell technology
From M2 Europharma -
Jun 18,
2009
18 June 2009 -
US development-stage drug maker ImmunoCellular
Therapeutics Ltd said today it has filed a
provisional US patent application relating to its
novel vaccine technology targeting cancer stem
cells.
[ Summary
]
Varian's
RapidArc Radiotherapy Technology Enables
Pioneering Cancer Treatments at Top Dutch Oncology
Center
From
PR Newswire US - Jun
18, 2009
Doctors in
the Netherlands have developed new ways to perform
radiosurgery on benign acoustic tumors using fast
and precise RapidArc radiotherapy technology from
Varian Medical Systems. Radiation oncologist Dr.
Frank Lagerwaard and his team compared RapidArc
with five-arc dynamic conformal arc radiosurgery
for vestibular schwannoma, a benign tumor that
affects hearing and balance.
[ Summary
]
NAMCP's Medical
Directors Resource Centers
The
purpose of NAMCP's Medical Directors Resource
Centers is to provide Medical Directors with
access to disease specific information and
resources and to improve patient
outcomes.
Accessing NAMCP's Medical
Directors Resource Centers will allow you
to:
Use screening tools to diagnose
Access treatment and best practice guidelines
Improve patient adherence and compliance
Improve patient outcomes
Better manage patients
Review cost of treatment versus overall
economic burden
Provide resources for your network physicians
Provide resources for patients
CLICK
HERE to access the Obesity Resource
Center
CLICK
HERE to access the Sleep Resource
Center
Sign
Up Today for the Exclusive Medical Director's
Website
Click
here to sign up for free access to
the exclusive Medical Director's Website. Features
include a discussion forum, career information,
and consolidated clinical links to important
managed care websites. You must be a Medical
Director to gain access to the website. Keep
current on all of the issues surrounding Medical
Directors in today's market. Access is free
for all Medical Directors. Please contact Jeremy
Williams at jwilliams@namcp.org
for more information! For those of you who are
not Medical Directors, please forward the link or
eNews to any Medical Directors in your company
that may be interested in the website.
CLICK THE FOLLOWING TITLES
TO PARTICIPATE IN THE ONLINE
CME/CEU
MS:
The New Treatment Paradigm: A Pathway to Success
for Improved Patient Outcomes
-
Supported by Bayer Healthcare, Inc.
How
to Improve Outcomes in a Patient Population of
Asthmatics
- Supported by
AstraZeneca
Stroke:
Primary and Secondary Prevention
-
Supported by Bristol-Myers Squibb
Economic
Value of the Prevention and Treatment of Diabetic
Ulcers
- Supported by KCI
Management
of the Liver Transplant Patient
-
Supported by Astellas
The
Relationship & Impact of Osteoporosis &
Breast Cancer in Post Menopausal
Women
- Supported by Eli Lilly
Implementation
of Comprehensive RSV Management Plan to Improve
Patient, Provider and Plan
Outcomes
- Supported by MedImmune,
Inc.
Diabetes:
When Behavior Modification is Not
Enough
- Supported by
GlaxoSmithKline
Health
Economic Implications of Wound Care and Limb
Preservation
- Supported by KCI,
Inc.
| Journal of Managed Care
Medicine |
|
Journal of Managed Care
Medicine Vol 12, Issue 2 Table of
Contents
 Below
you will find the table of contents for the
current issue of JMCM. You can click
here to visit our main journal page, or
click on each individual article below to visit
their article page and then download the
PDF!
Click
the titles below to visit the indvidual article
download page.
How
to Improve Outcomes in a Patient Population of
Asthmatics
Gary Owens,
MD
Stroke
Prevention in an At Risk
Population
John Varras,
MD
Economic
Value of the Prevention & Treatment of
Diabetic Ulcers
Lawrence
Lavery, DPM, MPH
Prevention
and Treatment of DVT and
PE
Darrell Harrington,
MD
Management
of the Liver Transplant
Patient
Steven Flamm,
MD
How
to Manage & Treat a Psoriatic Arthritis
Patient Population to Improve Patient
Outcomes
Phillip Mease,
MD
Complete
12.2
Issue
| Join NAMCP's LinkedIn
Group! |
|
This is a GREAT way to network with other
members, send them direct messages, post comments
or questions and learn more about your colleagues
working in other areas of managed care! If you are
a member of this professional, social network,
please search groups for NAMCP and request to join
our group for ongoing discussions, networking and
interaction with other
members!
Visit NAMCP's Career
Center!
To find a job or fill a
position, visit http://careers.namcp.org.
You can also click on the links following each
individual job below to be taken to their new page
on our career center.
Job
seekers and employers have discovered the
advantages of searching online for the best jobs
and for qualified candidates to fill them. But,
the mass-market approach of the mega job boards
may not be your best avenue.
NAMCP's Career
Center gives employers and job seeking managed
care professionals a better way to find one
another and make that perfect career
fit.
For Job Seekers: Post your
resume; Search job listings; Set up Search Agents;
and have new postings sent to you via
email.
For Employers: Post your
jobs; Target a focused audience of candidates;
Search resumes; Track applications; Promote your
company online.
If you
would like to post a job on Managed Care eNews,
please contact Sloane Reed at
sreed@namcp.org or 804-527-1905 for
rate information.
In
accordance with our mission, to enhance the
ability of our members to succeed in their
careers, we are pleased to offer comprehensive
career consultation and national executive
placement services. As a benefit of membership for
our client organizations, i.e., anyone seeking to
hire experienced staff, we offer exceptional
executive search services and at a discounted
rate. We have access to the highest caliber of
managed care talent and have a distinguished track
record in placing physician and nurse executives
as well as executive operations personnel (CEO,
COO, CFO, Director of Managed Care, Network
Development, etc.)
If you have an available
position or have an interest in our placement
service, please contact David Mara at
(804)527-1905 or e-mail at dmara@namcp.org.
For a more detailed job description for any of
the jobs listed below, please contact Dave Mara at
804.527.1905 or email him at dmara@namcp.org
You
can also CLICK HERE to visit our Job
Placement and Career Counseling page to view the
full descriptions for all of these jobs and
more!
Medical Director, Clinical Research, North
America
New Jersey
Job
Summary
The Medical Director-Clinical
Research, North America reports to the Executive
Medical Director. The incumbent is responsible for
developing and implementing product development
strategies initially in the Gastroenterology
therapeutic area but later may involve in other
therapeutic areas as derived from the company's
pipeline and/or in licensed development products.
While the individual is expected to manage the
conduct of clinical trials in the US, there is a
strong component involving participation in global
project development teams. The Medical Director
will be expected to undertake all the duties
normally associated with the execution of clinical
trials and to establish clinical advisory boards
in the areas of product development.
For
more information, please call David Mara at
804.527.1905. To review additional positions go to
www.nexushc.com
Medical Director
New
Jersey
Job Summary
The
Medical Director reports to the Vice President of
Infertility and Orthopedics. The incumbent is
responsible for developing and implementing
product development strategies initially in the
OBGYN therapeutic areas but later may involve in
other therapeutic area; as derived from the
company pipeline and/or in licensed development
products. While the individual is expected to
manage the conduct of clinical trials in the US
there is a strong component involving
participation in global project development teams
managed from the company's International Center in
Copenhagen. The Medical Director will be expected
to undertake all the duties normally associated
with the execution of clinical trials and to
establish clinical advisory boards in the areas of
product development.
For more information,
please call David Mara at 804.527.1905. To review
additional positions go to www.nexushc.com
Medical Director, Clinical Research, North
America
New Jersey
Job
Summary
The Medical Director-Clinical
Research, North America reports to the Executive
Medical Director. The incumbent is responsible for
developing and implementing product development
strategies initially in the Urology therapeutic
area but later may involve in other therapeutic
area as derived from the company's pipeline and/or
in licensed development products. While the
individual is expected to manage the conduct of
clinical trials in the US there is a strong
component involving participation in global
project development teams. The Medical Director
will be expected to undertake all the duties
normally associated with the execution of clinical
trials and to establish clinical advisory boards
in the areas of product development.
For
more information, please call David Mara at
804.527.1905. To review additional positions go to
www.nexushc.com
Chief Medical Officer
San Francisco,
CA
Job Summary
The Chief
Medical Officer (CMO) for the Healthcare Services
organization will be integral in the realization
of the health plan's mission, by providing
leadership and direction for health management and
clinical quality improvement strategies, providing
greater value to its members through pharmacy and
medical management, and optimally functioning
management systems.
For more information,
please call David Mara at 804.527.1905. To review
additional positions go to www.nexushc.com
Associate Medical Director
Nashville, TN
Job Summary
Working with the
Chief Medical Director, oversees medical care for
the health plan's products and services and
oversees the health care needs of the membership.
Serves as a medical manager and policy advisor to
the company and health plan Chief Medical
Director. Is accountable for and provides
professional leadership and direction to the
utilization/cost management and clinical quality
management functions. Works collaboratively with
other plan functions that interface with medical
management such as provider relations, member
services, benefits and claims management, etc.
Assists (as determined by the plan Chief Medical
Director) in short and long range program
planning, total quality management (quality
improvement) and external
relationships.
For more information, please
call David Mara at 804.527.1905. To review
additional positions go to www.nexushc.com
Chief Medical Officer
Nashville, TN
Overview
Oversees all
medical care for the health plan's products and
services. Oversees the health care needs of the
membership. Serves as the principal medical
manager and policy advisor to the company and
health plan CEO or COO. Is accountable for and
provides professional leadership and direction to
the utilization/cost management and clinical
quality management functions. Works
collaboratively with other plan functions that
interface with medical management such as provider
relations, member services, benefits and claims
management, etc.
Please
click here to visit the webpage for this
job opportunity, including a detailed job
description!
MEDICARE HMO EXPANDING - NEW MARKET
OPPORTUNITY
Medical Director
Mobile,
AL
Job Summary
This position
is responsible for the administration of all
medical services for the corporation. It is
responsible for the coordination of medical
policy, peer review, quality management,
legal/medical issues, and the effectiveness of the
Medical Management Program.
Please
click here to visit the webpage for this
job opportunity, including a detailed job
description!
Medical Director
Virtual
Job
Summary
A leading healthcare technology and
service company that provides solutions for
healthcare organizations, has a unique experience
base, extensive healthcare information and
advantaged technology applications which create
value through reduced medical costs, reduced
administrative costs and improved care
coordination is seeking a Medical Director to
support a growing client base and maintain their
competitive advantage in the depth of clinical
logic.
The Medical Director is instrumental
within the company in directing the Logic
Committee (Medical Policy Committee) which is
composed of medical directors, coding analysts,
provider relations, contracting people, etc. At
the Logic Committee, the company goes through
their Global Medical Policy document as it relates
to claims coding and then subsequently reviews
individual edits that have potential value for the
client.
Please direct all inquires to Dave
Mara at 804-527-1905.
Manager, Provider Relations and
Contracting
Austin, TX; Ft. Lauderdale; Orlando
and Tampa, FL
Summary
This
behaviorial health company is a multi-line managed
care organization that provides Medicaid-related
programs to organizations and individuals through
government subsidized programs. We have an
excellent opportunity for a Manager of Provider
Relations and Contracting. This position will
implement development activities for the
recruitment, contracting and retention of
providers. Negotiate contracts and develop
strategies and methodologies for specific network
development initiatives.
Please
click here to visit the webpage for this
job opportunity, including a detailed job
description!
| | |
| Managed Care eNews for June 24,
2009 |
Produced by NAMCP, AAMCN, AAIHDS
4435 Waterfront Drive, Suite 101
Glen
Allen, VA 23060
Telephone:
804-527-1905
Fax: 804-747-5316 |
Click "Opt-out of this
newsletter" at the top of the newsletter or
contact Jeremy Williams at jwilliams@namcp.org
or 804-527-1905 to be taken off the
list | | | | |
|
| JOURNAL OF MANAGED CARE MEDICINE
(JMCM) |
|
Vol. 12, No. 2 has been
released! Scroll below to the Journal Section
below for downloadable
articles! | | |
| EMPLOYMENT
OPPORTUNITIES |
|
Call Dave Mara at (804) 527-1905 for
information on any of the following job
openings.
Medical Director, Clinical Research, North
America, New Jersey
Medical Director, New Jersey
Chief Medical Officer, San Francisco, CA
Medical Director, Mobile, AL
Medical Director, Virtual
Chief Medical Officer, Nashville, TN
Manager, Provider Relations and Contracting,
Austin, TX; Ft. Lauderdale, Orlando and Tampa,
FL
VP of Health Services, Birmingham, AL, Miami,
FL and New Orleans, LA
VP, Health Care Management Services, Multiple
Locations
Senior Medical Director, Houston,
TX
For more information or for more
detailed job descriptions, please contact Dave
Mara at 804.527.1905 or email your resume to dmara@namcp.org
| | | |
